Amphastar Pharmaceuticals
AMPH
#4555
Rank
NZ$3.10 B
Marketcap
$64.64
Share price
-5.82%
Change (1 day)
-27.90%
Change (1 year)

Earnings for Amphastar Pharmaceuticals (AMPH)

Earnings in 2024 (TTM): NZ$0.35 Billion

According to Amphastar Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.72 Billion. In 2023 the company made an earning of NZ$0.35 Billion, an increase over its 2022 earnings that were of NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Amphastar Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.35 B0.89%
2023 NZ$0.35 B68.4%
2022 NZ$0.21 B38.65%
2021 NZ$0.15 B1596.75%
2020 NZ$8.93 M-91.7%
2019 NZ$0.10 B-723.23%
2018 -NZ$17.28 Million-516.29%
2017 NZ$4.14 M-85.44%
2016 NZ$28.48 M-270.31%
2015 -NZ$16.73 Million-46.53%
2014 -NZ$31.29 Million-196.44%
2013 NZ$32.43 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.26 Billion-163.71%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$63.02 Million-116.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$26.81 Million-106.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.15 Billion-136.70%๐Ÿ‡บ๐Ÿ‡ธ USA